# OnCo record epha2 (target). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/targets/epha2/>
  a schema:BioChemEntity ;
  onco:kind "target" ;
  schema:identifier "epha2" ;
  schema:name "EphA2 receptor"@en ;
  schema:description "EphA2 is a cell-guidance receptor that many solid tumours overexpress; dasatinib and regorafenib block it among their many kinase targets, and it is being tested as an antibody-drug conjugate and CAR-T target."@en ;
  schema:url <https://onco.cc/targets/epha2/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/EPH_receptor_A2>, <https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:3386>, <https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000142627>, <https://www.uniprot.org/uniprotkb/P29317/entry>, <https://www.ncbi.nlm.nih.gov/gene/1969> ;
  schema:citation <https://www.uniprot.org/uniprotkb/P29317/entry>, <https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:3386>, <https://www.ebi.ac.uk/chembl/explore/target/CHEMBL2068> ;
  schema:alternateName "EPHA2" ;
  onco:targetClass "kinase" ;
  onco:firstDescribed "1990"^^xsd:gYear ;
  onco:cancers <https://onco.cc/cancers/glioblastoma/>, <https://onco.cc/cancers/ovarian/> ;
  onco:drugs <https://onco.cc/drugs/dasatinib/>, <https://onco.cc/drugs/regorafenib/> .
